Clavon Neo Dry Syrup (Amoxicillin·Clavulanate Potassium (14:1))
Amoxicillin Hydrate 54.55g · Dilute Potassium Clavulanate 3.9g
Syrup · Prescription medication · Combination
Kujoo Pharmaceutical Co., Ltd.
MFDS item code 201701091 · Notified 2017.02.28
Treatment of recurrent or persistent acute otitis media in children with risk factors
This medicine is used for the treatment of recurrent or persistent acute otitis media in pediatric patients. It is particularly effective in children who have been treated with antibiotics for acute otitis media within the past 3 months, those under the age of 2, or those attending daycare facilities. The drug acts against major pathogens such as Streptococcus pneumoniae, Haemophilus influenzae (including beta-lactamase producing strains), and Moraxella catarrhalis (including beta-lactamase producing strains). This medicine can improve the symptoms of acute otitis media and prevent its recurrence.
○ Adults: There is no experience with the use of this medicine in adults. ○ Patients with hepatic impairment: Use this medicine with caution in patients with hepatic impairment and monitor liver function regularly. ○ To minimize the possibility of gastrointestinal disturbances, administer this medicine at the start of a meal. Administration at the start of a meal increases the absorption of potassium clavulanate.
○ Pediatric patients 3 months of age and older: The recommended dose of this medicine, based on the amoxicillin content (600 mg/5 mL), is 90mg/kg/day divided at 12-hour intervals, administered for 10 days. 8kg: Administer 3.0mL every 12 hours 12kg: Administer 4.5mL every 12 hours 16kg: Administer 6.0mL every 12 hours 20kg: Administer 7.5mL every 12 hours 24kg: Administer 9.0mL every 12 hours 28kg: Administer 10.5mL every 12 hours 32kg: Administer 12.0mL every 12 hours 36kg: Administer 13.5mL every 12 hours ○ Pediatric patients weighing 40kg or more: There is no experience with the use of this medicine in pediatric patients weighing 40kg or more.
This drug contains the artificial sweetener aspartame, which is broken down in the body into phenylalanine. Therefore, patients with a genetic disorder known as phenylketonuria should not take this medicine. The daily allowable intake of aspartame should be adjusted to be below the recommended levels by WHO, using the minimum possible amount, with a maximum daily dosage for adults being 2.4g. Patients who have had hypersensitivity reactions to any of the ingredients in this drug or to beta-lactam antibiotics should not be administered this medicine. Additionally, patients with concomitant viral infections such as infectious mononucleosis or lymphocytic leukemia, or those with a history of hepatic dysfunction or jaundice caused by this drug or penicillin should also avoid this medication. Since this drug contains lactose, it should not be administered to patients with lactose intolerance, lactase deficiency, or glucose-galactose malabsorption. Patients with hepatic dysfunction or moderate to severe renal impairment should use this drug cautiously and may need dosage interval adjustments. Patients with allergies, those who find it hard to take orally, elderly patients, and those in poor general condition should also be cautious. Patients with gastrointestinal diseases accompanied by vomiting or diarrhea may not absorb the drug adequately, hence they should take it with care. This drug is generally safe, but side effects such as diarrhea, vomiting, rash, contact dermatitis, and others may occur. Especially, diarrhea and vomiting are common adverse reactions that may lead to discontinuation of the drug. In severe cases, symptoms such as pseudomembranous colitis, hepatitis, severe skin reactions, blood abnormalities, renal impairment, and central nervous system abnormalities may occur, so patients should consult a doctor immediately if such symptoms arise. As this drug is a penicillin-based antibiotic, hypersensitivity reactions can be severe, and there is a possibility of anaphylactic shock, so patient status should be closely monitored after administration. If diarrhea occurs during or after antibiotic use, pseudomembranous colitis should be suspected, and administration should be stopped immediately, followed by appropriate treatment. This drug should only be used for the treatment of bacterial infections and is ineffective against viral infections. Even if symptoms improve, it is important to take it consistently for the prescribed duration to prevent the development of resistant bacteria. Shake well before use, store in the refrigerator after preparation, and consume within 7 days. Women who are pregnant or breastfeeding should carefully consider the risks and benefits of this drug, particularly during the first 3 months of pregnancy where it is advisable not to take it. This drug has not been proven safe for infants under 3 months of age.
Contact dermatitis, diarrhea, vomiting, candidiasis, rash, pseudomembranous colitis, dyspepsia, stomatitis, gastritis, glossitis, black hairy tongue, nausea, loss of appetite, abdominal pain, abdominal bloating, constipation, colonic pain, hyperacidity, fecal incontinence, dry mouth, acute pancreatitis, candidiasis, antibiotic-associated colitis, elevated AST, elevated ALT, elevated ALP, elevated LDH, elevated serum bilirubin, hepatitis, cholestatic jaundice, itching, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, vesicular eczema, acute generalized exanthematous pustulosis, eosinophilia, drug reaction (DRESS), angioedema, anaphylaxis, serum sickness syndrome, hypersensitivity vasculitis, bronchospasm, dyspnea, laryngeal edema, anaphylactic shock, reversible leukopenia, thrombocytopenia, hemolytic anemia, anemia, thrombocytopenic purpura, eosinophilia, leukemia, agranulocytosis, lymphocytopenia, thrombocytosis, bone marrow suppression, prolonged bleeding time, prolonged prothrombin time, mucosal candidiasis, vaginal itching, vaginal burning, increased discharge, restlessness, anxiety, behavioral changes, confusion, drowsiness, insomnia, hyperactivity, dizziness, headache, seizures, aseptic meningitis, acute kidney failure, interstitial nephritis, hematuria, crystalluria, vitamin K deficiency symptoms, vitamin B deficiency symptoms, tooth discoloration, linear IgA disease, taste disturbances, malaise, dermatitis, oral edema, gastric pain, fluid and electrolyte imbalance, hyperactivity, drowsiness, interstitial nephritis, functional renal failure, epileptic seizures, hypersensitivity shock, skin reaction, bleeding, pancytopenia
Not everyone experiences these, and they can vary from person to person.
This medicine should be stored in a tightly sealed container to protect it from air and moisture, preferably at a cool and dry temperature between 1 to 25 degrees Celsius. Storing it this way helps maintain the drug's effectiveness.
A white to pale yellow powder with a peculiar smell, used as a syrup that is dissolved before use.
50mL/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Amoxicillin Hydrate 54.55g · Dilute Potassium Clavulanate 3.9g
Syrup · Prescription medication · Combination
Kujoo Pharmaceutical Co., Ltd.
CombinationAmoxicillin Hydrate 500mg · Dilute Potassium Clavulanate 215.52mg
Tablet · Prescription medication · Combination
Geonil Pharmaceutical Co., Ltd.
CombinationAmoxicillin Hydrate 125mg · Dilute Potassium Clavulanate 107.76mg
Tablet · Prescription medication · Combination
Geonil Pharmaceutical Co., Ltd.
CombinationAmoxicillin Hydrate 250mg · Dilute Potassium Clavulanate 212.73mg
Tablet · Prescription medication · Combination
International Pharmaceutical Co., Ltd.
CombinationAmoxicillin Hydrate 250mg · Dilute Potassium Clavulanate 215.52mg
Tablet · Prescription medication · Combination
HLB Pharmaceutical Co., Ltd.
CombinationAmoxicillin Hydrate 500mg · Dilute Potassium Clavulanate 215.52mg
Tablet · Prescription medication · Combination
HLB Pharmaceuticals Co., Ltd.
CombinationAmoxicillin Hydrate 250mg · Dilute Potassium Clavulanate 215.52mg
Tablet · Prescription medication · Combination
Dong Sung Pharmaceutical Co., Ltd.
CombinationAmoxicillin Hydrate 250mg · Dilute Potassium Clavulanate 212.73mg
Tablet · Prescription medication · Combination
Youngjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.